
Sign up to save your podcasts
Or


Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.
By American Academy of Neurology4.7
285285 ratings
Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.

317 Listeners

496 Listeners

51 Listeners

3,340 Listeners

12 Listeners

1,150 Listeners

23 Listeners

194 Listeners

512 Listeners

134 Listeners

366 Listeners

190 Listeners

372 Listeners

318 Listeners

81 Listeners